(S1 (S (S (NP (NN Angiotensin) (CD II)) (VP (VBZ induces) (NP (NP (JJ soluble) (JJ fms-Like) (NN tyrosine) (NN kinase-1)) (NN release)) (PP (IN via) (NP (NP (NN calcineurin) (NN signaling) (NN pathway)) (PP (IN in) (NP (NN pregnancy))))))) (. .)))
(S1 (S (S (NP (NP (JJ Maternal) (JJ endothelial) (NN dysfunction)) (PP (IN in) (NP (NN preeclampsia)))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NP (VBN increased) (JJ soluble) (JJ fms-like) (NN tyrosine) (NN kinase-1)) (PRN (-LRB- -LRB-) (NP (NN sFlt-1)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ circulating) (NN antagonist)) (PP (IN of) (NP (NP (JJ vascular) (JJ endothelial) (NN growth) (NN factor)) (CC and) (NP (JJ placental) (NN growth) (NN factor)))))))))) (. .)))
(S1 (S (S (NP (NP (NN Angiotensin) (CD II)) (PRN (-LRB- -LRB-) (NP (NN Ang) (CD II)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN vasoconstrictor)) (SBAR (WHNP (WDT that)) (S (VP (VBZ increases) (ADJP (JJ concomitant) (PP (IN with) (NP (NN sFlt-1)))) (PP (IN during) (NP (NN pregnancy))))))))) (. .)))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP we)) (VP (VBD speculated) (SBAR (IN that) (S (NP (NN Ang) (CD II)) (VP (MD may) (VP (VB promote) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN sFlt-1))) (PP (IN in) (NP (NN pregnancy)))))))))) (. .)))
(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP report) (SBAR (IN that) (S (NP (NP (NN infusion)) (PP (IN of) (NP (NN Ang) (CD II)))) (ADVP (RB significantly)) (VP (VBZ increases) (NP (NP (JJ circulating) (NNS levels)) (PP (IN of) (NP (NN sFlt-1))) (PP (IN in) (NP (JJ pregnant) (NNS mice)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG demonstrating) (SBAR (IN that) (S (NP (NN Ang) (CD II)) (VP (VBZ is) (NP (NP (DT a) (NN regulator)) (PP (IN of) (NP (NN sFlt-1) (NN secretion)))) (ADVP (FW in) (FW vivo))))))))))) (. .)))
(S1 (S (ADVP (RB Furthermore)) (, ,) (NP (NN Ang) (CD II)) (VP (VBD stimulated) (NP (NN sFlt-1) (NN production)) (PP (IN in) (NP (NP (DT a) (NN dose-)) (CC and) (NP (JJ time-dependent) (NN manner)))) (PP (PP (IN from) (NP (NP (JJ human) (JJ villous) (NNS explants)) (CC and) (NP (VBN cultured) (NNS trophoblasts)))) (CC but) (PP (RB not) (IN from) (NP (JJ endothelial) (NNS cells)))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NNS trophoblasts)) (VP (VBP are) (NP (NP (DT the) (JJ primary) (NN source)) (PP (IN of) (NP (NN sFlt-1))) (PP (IN during) (NP (NN pregnancy)))))))))) (. .)))
(S1 (S (S (SBAR (IN As) (S (VP (VBN expected)))) (, ,) (NP (JJ Ang) (JJ II-induced) (NN sFlt-1) (NN secretion)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NP (JJ endothelial) (NN cell) (NN migration)) (CC and) (NP (ADJP (FW in) (FW vitro)) (NN tube) (NN formation)))))))) (. .)))
(S1 (S (S (NP (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS studies)) (PP (IN with) (NP (NP (NN losartan)) (, ,) (NP (NP (JJ small) (VBG interfering) (NN RNA)) (ADJP (JJ specific) (PP (IN for) (NP (NP (NN calcineurin)) (CC and) (NP (NN FK506))))))))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (ADJP (NN Ang) (JJ II-mediated)) (NN sFlt-1) (NN release)) (VP (VBD was) (PP (IN via) (NP (NP (NP (NN Ang) (CD II) (NN type) (CD 1) (NN receptor)) (NN activation)) (CC and) (NP (NN calcineurin) (NN signaling)))) (, ,) (ADVP (RB respectively))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS findings)) (VP (VP (VBP reveal) (NP (NP (DT a) (ADJP (RB previously) (JJ unrecognized)) (JJ regulatory) (NN role)) (PP (IN for) (NP (NN Ang) (CD II))) (PP (IN on) (NP (NP (NN sFlt-1) (NN expression)) (PP (IN in) (NP (ADJP (ADJP (JJ murine)) (CC and) (ADJP (JJ human))) (NN pregnancy))))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ elevated) (NN sFlt-1) (NNS levels)) (PP (IN in) (NP (NN preeclampsia)))) (VP (MD may) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (NP (DT a) (NN dysregulation)) (PP (IN of) (NP (DT the) (JJ local) (JJ renin/angiotensin) (NN system))))))))))))) (. .)))
